Thank you for helping us raise $3 MILLION in support of #beNeFit XI! We cannot thank our sponsors enough for the tremendous outpouring of support this year. See you November 18th!
#beNeFitXI#nfforward#endNF
Meet our 2023 Intern, Caroline Miota! She recently graduated from Michigan State University and her primary responsibilities include assisting in the execution of beNeFit XI. Caroline can't wait to work with our great donors and supporters!
#nfforwarddetroit#beNeFitXI
On May 17, 2023, landmarks across the world lit up in blue and green for the Shine a Light Campaign promoting NF awareness. Many buildings across Detroit showed their support for National NF Awareness Day. Thank you to all the participating buildings💙💚
#EndNF#ShineALightonNF
We have partnered with @NFForward and @ChildrensTumor to launch the Bow Tie campaign. We're dedicating our 2022-23 season to Nick Gilbert and the millions of others impacted by neurofibromatosis (NF).
Learn more at https://t.co/mEqaLx9AQ7!
On May 17, 2022, landmarks across the world lit up in blue and green for the Shine a Light Campaign promoting NF awareness. Check out some participating buildings in the Detroit area and go to our website for the full list!
On World NF Awareness Day, and every day we strive to shine a light on the cause and the people living with NF. We are committed to continuing our work and supporting efforts to accelerate a cure.
#MakeNFVisible#endnf#NF
Today is the day! If you are watching from the comfort of your home click the link below to join the live stream. See you soon!
https://t.co/dx0LwNMVmr
We are excited to announce a new study aimed to understand the mechanisms of vision loss caused by NF1-OPG. Led by Drs. Rob Avery @ChildrensPhila and Jeff Goldberg @StanfordMed, findings will help inform future therapies and validate existing models.
https://t.co/ZqS1NynQUJ
GFF is excited to announce a new clinical study in collaboration with @CHOPCancerCntr and the Children's Oncology Group to validate optical coherence tomography (OCT) as a biomarker for treatment response in NF1 patients with optic pathway gliomas. https://t.co/fW2LMAz0HP
A clinical study funded by @GilbertFamilyFd will allow CHOP researchers to partner with the Children's Oncology Group to validate optical coherence tomography (OCT) to measure NF1-related progressive vision loss. Learn more at: https://t.co/4Y8m4D6KL0. #ForBreakthroughs
Through the end of the month, Bedrock and community partners are ‘Shining a Light’ on Neurofibromatosis (NF) by illuminating buildings blue and green. Shine a Light on NF is an awareness campaign spearheaded by @ChildrensTumor. #EndNF
In support of the Shine a Light on NF campaign, @brodersachse’s The Albert - Capitol Park and The Scott at Brush Park went blue yesterday on World NF Awareness Day! Let’s #EndNF together! Beyond NF Awareness Month, please help us continue to #makeNFvisible.